Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Apolo Website

Andrea B. Apolo, M.D.

Selected Publications

1)  Yavuz S, Apolo AB, Kummar S, Del Rivero J, Madan RA, Shawker T, Reynolds J, Celi FS.
Cabozantinib-induced thyroid dysfunction: a review of two ongoing trials for metastatic bladder cancer and sarcoma.
Thyroid. 24: 1223-31, 2014.
2)  Sternberg CN, Apolo AB.
Everything old is new again! Neoadjuvant chemotherapy in the treatment of muscle-invasive bladder cancer.
J. Clin. Oncol. 32: 1868-70, 2014.
3)  Apolo AB, Kim JW, Bochner BH, Steinberg SM, Bajorin DF, Kevin Kelly W, Agarwal PK, Koppie TM, Kaag MG, Quinn DI, Vogelzang NJ, Sridhar SS.
Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States.
Urol. Oncol. 32: 637-44, 2014.
4)  Park JC, Citrin DE, Agarwal PK, Apolo AB.
Multimodal management of muscle-invasive bladder cancer.
Curr Probl Cancer. 38: 80-108, 2014.
5)  Cowan NG, Chen Y, Downs TM, Bochner BH, Apolo AB, Porter MP, La Rochelle JC, Amling CL, Koppie TM.
Neoadjuvant chemotherapy use in bladder cancer: a survey of current practice and opinions.
Adv Urol. 2014: [Epub ahead of print], 2014.
6)  Nakrani RN, Ghosh A, Richard Lee C, Agarwal PK, Apolo AB, Cowen EW.
New facial papules in a 66-year-old woman with bladder cancer.
J. Am. Acad. Dermatol. [Epub ahead of print], 2014.
7)  Agarwal N, Apolo AB, Tsao C, Lee KM, Godbold JH, Soto R, Poole A, Gimpel-Tetra K, Lowe N, Oh WK, Galsky MD.
Phase Ib/II Trial of Gemcitabine, Cisplatin, and Lenalidomide as First-Line Therapy in Patients With Metastatic Urothelial Carcinoma.
Oncologist. [Epub ahead of print], 2014.
8)  Pichard DC, Hensley JR, Williams E, Apolo AB, Klion AD, DiGiovanna JJ.
Rapid development of migratory, linear, and serpiginous lesions in association with immunosuppression.
J. Am. Acad. Dermatol. 70: 1130-4, 2014.
9)  Apolo AB, Hoffman V, Kaag MG, Latini DM, Lee CT, Rosenberg JE, Knowles M, Theodorescu D, Czerniak BA, Efstathiou JA, Albert ML, Sridhar SS, Margulis V, Matin SF, Galsky MD, Hansel D, Kamat AM, Flaig TW, Smith AB, Messing E, Zipursky Quale D, Lotan Y.
Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward.
Urol. Oncol. [Epub ahead of print], 2014.
10)  Ghosh M, Brancato SJ, Agarwal PK, Apolo AB.
Targeted therapies in urothelial carcinoma.
Curr Opin Oncol. 26: 305-20, 2014.
Click Here to View Expanded Bibliography.

This page was last updated on 8/21/2014.